Metropolitan Life Insurance Company (MetLife)’s Nikola Corporation Common Stock NKLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,345
Closed -$42K 2219
2024
Q1
$42K Buy
1,345
+194
+17% +$4.17K ﹤0.01% 1493
2023
Q4
$30.2K Hold
1,151
﹤0.01% 1718
2023
Q3
$54.2K Buy
1,151
+55
+5% +$2.86K ﹤0.01% 1358
2023
Q2
$45.4K Buy
1,096
+480
+78% +$13.2K ﹤0.01% 1480
2023
Q1
$22.3K Sell
616
-90
-13% -$5.9K ﹤0.01% 1834
2022
Q4
$45.7K Buy
706
+107
+18% +$8.94K ﹤0.01% 1531
2022
Q3
$63.2K Hold
599
﹤0.01% 1294
2022
Q2
$85.5K Buy
599
+92
+18% +$18.8K ﹤0.01% 1151
2022
Q1
$163K Sell
507
-1,522
-75% -$388K 0.01% 926
2021
Q4
$601K Buy
2,029
+32
+2% +$10.7K 0.01% 1301
2021
Q3
$639K Buy
1,997
+130
+7% +$45.5K 0.01% 1287
2021
Q2
$1.01M Buy
+1,867
New +$778K 0.01% 997

Other funds holding NKLA

Metropolitan Life Insurance Company (MetLife)'s NKLA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nikola Corporation Common Stock (NKLA) in Q2 2024, closing a stake of 1,345 shares — an estimated $42K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NKLA in Q2 2021 and held it in 12 quarters. The position peaked at $1.01M in Q2 2021. 159 funds tracked by Wall St. Rank hold NKLA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nikola Corporation Common Stock position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,345 Nikola Corporation Common Stock shares in Q2 2024, an estimated $42K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nikola Corporation Common Stock in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nikola Corporation Common Stock position peaked at $1.01M in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Nikola Corporation Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.